Micronuclei in cytokinesis-blocked lymphocytes may predict patient response to radiotherapy.
We have applied the cytokinesis-block micronucleus assay to peripheral blood lymphocytes of patients undergoing radiotherapy in pelvic and pulmonary sites, in order to evaluate the individual cytogenetic response. Our cytogenetic data correlated with the equivalent whole-body dose are homogeneous and compare well with the data presented by other authors. We have used an exponential mathematical formula to calculate the attenuation of the cytogenetic effect with time. The k coefficient (cytogenetic recovery factor) in the formula expresses the degree of attenuation. In lymphocytes from patients after radiotherapy, the trend of the micronucleus frequency observed after 2 Gy of in vitro X-irradiation demonstrates that the cytogenetic effect obtained in vitro is added to that obtained in vivo. The k coefficient is inversely proportional to the micronucleus frequency observed after 2 Gy in vitro. The micronucleus assay and the cytogenetic recovery factor are proposed as suitable diagnostic tools for application in the field of radiotherapy.
Catena
C
C
AMB-BIO, ENEA, CR-Casaccia, Rome, Italy.
Conti
D
D
Parasacchi
P
P
Marenco
P
P
Bortolato
B
B
Botturi
M
M
Leoni
M
M
Portaluri
M
M
Paleani-Vettori
P G
PG
Righi
E
E
D004307:Dose-Response Relationship, Radiation; D006801:Humans; D008214:Lymphocytes / Q000528:radiation effects* / Q000648:ultrastructure; D015162:Micronucleus Tests; D011836:Radiation Tolerance; D011878:Radiotherapy